Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 9Pain 8Pain, Postoperative 5Breast Neoplasms 5Depression 4Agnosia 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain, Intractable 2Chronic Pain 2Acute Pain 2Prostatic Neoplasms 1Postoperative Analgesia 1Peripheral Nervous System Diseases 1Pelvic Neoplasms 1Pancreatic Neoplasms 1Neurotoxicity Syndromes 1Neuralgia 1Mucositis 1Lymphoma, Follicular 1Lung Neoplasms 1Hypoxia 1Head and Neck Neoplasms 1Emergence Delirium 1Depressive Disorder, Major 1Colorectal Neoplasms 1Colonic Neoplasms 1Choledocholithiasis 1Choledochal Cyst 1Cholangitis 1Cancer Pain 1

Interventions

Paclitaxel 5Vincristine 3Oxaliplatin 3Mental Status and Dementia Tests 3Magnetic Resonance Spectroscopy 3Carboplatin 3Amifostine 3xaliproden 2glucarpidase 2Taxes 2Radiotherapy 2Psychiatric Rehabilitation 2Procarbazine 2Methotrexate 2Magnesium Sulfate 2Leucovorin 2Doxorubicin 2Cyclophosphamide 2Cisplatin 2Calcium Gluconate 22,2'-dithiodiethanesulfonic acid 2neurotropin 1glutamic acid diethyl ester 1eribulin 1axicabtagene ciloleucel 1Vitamin E 1Trastuzumab 1Thioctic Acid 1Thalidomide 1Tadalafil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurotoxicity Syndromes × Ketamine × Clear all
NCT00471445 2015-11-09

Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Cancer Patients

University of Rochester

Phase 3 Completed
462 enrolled 14 charts

Pain, Peripheral Nervous System Diseases, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡